Puma Biotechnology Inc reports results for the quarter ended in March - Earnings Summary

Puma Biotechnology

02/05/2024 22:53

* Puma Biotechnology Inc  PBYI.OQ  reported a quarterly
adjusted
loss of 10 cents​​ per share for the quarter ended in March,
lower than the same quarter last year, when the company reported
EPS of 3 cents.  The mean expectation of three analysts for the
quarter was for a loss of 22 cents per share. Wall Street
expected results to range from -23 cents to -21 cents per share.
    * Revenue fell 17% to $43.80 million from a year ago;
analysts
expected $41.05 million. 
    * Puma Biotechnology Inc's reported EPS for the quarter was
a loss
of 10 cents​.
    * The company reported a quarterly loss of $4.8 million.
    * Puma Biotechnology Inc shares had fallen by 6.6% this
quarter and gained 14.3% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Puma
Biotechnology Inc is $4.00 
This summary was machine generated from LSEG data May 2 at 09:53
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.22          -0.10          Beat
 Dec. 31 2023      0.30           0.26           Missed
 Sep. 30 2023      0.08           0.12           Beat
 Jun. 30 2023      0.01           0.05           Beat